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The allogeneic bone marrow transplantation usually preceded by induction chemotherapy, in fit patients, represents the gold
standard in the acute myeloid leukaemia. In the last years, many trials have been set up with the view of improving the number of
remissions during the induction by adding new drugs. Several early or late side effects have been described in the literature. We
herein present a patient with acute myeloid leukaemia patient who, after chemotherapy, developed ascites that turned out to be
abdominal sarcoidosis.
1. Case Report
A 68-year-old Caucasian lady presented to the Haematology
Department with pancytopenia and palpitations in March
2009. She had a pastmedical history of uterine fibroids neces-
sitating hysteroannessectomy, diverticulitis, oesophageal
reflux, and hypercholesterolemia, as well as a family history
of familial Polyposis coli for which she was under surveillance.
She was taking ranitidine and simvastatin regularly.
Bonemarrow biopsy revealed hypercellular bonemarrow
with architectural distortion of haemopoiesis, a reduction in
mature granulocytes and infiltration of myeloblasts (which
madeup 30–40%of all cells seenwithin the biopsy) consistent
with acute myeloid leukaemia (AML NOS M1 category,
cytogenetics 46 XX). She was commenced on theAML16 trial
and treated with Daunorubicin, Clofarabine, Gemtuzumab,
and nine months maintenance Azacytidine. Allogenic bone
marrow transplant was considered but was not pursued at the
patient’s request. On completion of five months of treatment
(October 2010), the patient was asymptomatic and a repeat
bone marrow biopsy demonstrated full remission.
Three months later (January 2011), the patient was admit-
ted with abdominal discomfort and distension. On exami-
nation, there was evidence of ascites with normal renal and
liver function, haemoglobin 12.6, white cell count 3.9, platelet
count 316, and an elevated CA125 at 320. Echocardiogram
demonstrated good biventricular function. Imaging of the
abdomen and pelvis confirmed gross ascites with no focal
liver lesion, but there was evidence of fat stranding in the
omentumwith small omental deposit on the computed tomo-
graphy of the abdomen and pelvis with contrast (Figure 1).
Subsequent MRI showed omental cake and mesenteric
deposits raising the possibility of peritoneal neoplasia or
mesothelioma. Abdominal paracentesis was performed and 4
litres of straw coloured fluid was drained. The serum-ascites
albumin gradient (SAAG)was 1with LDH95,white cell count
923 (90% lymphocytes) and no malignant cells seen. Flow
cytometry of the ascitic fluid confirmed no evidence of AML.
A total body CT scan was performed to rule out any primary
solid tumour and there was no evidence of any solid tumour.
The patient continued to require frequent ascitic drainage
every 3-4 weeks with approximately 4 litres of fluid drained
on each occasion.
A laparoscopic peritoneal biopsy was arranged; macro-
scopically there was evidence of some miliary deposits on
the dome of the bladder and along the peritoneum surface
(Figure 2). This was followed by a cystoscopy which did not
demonstrate any abnormalities.
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Figure 1: CT scan of the abdomen and pelvis with contrast showing
heterogeneous fat/soft-tissue density within the greater omentum
(see white arrow). There is also extensive ascites.
Figure 2: Laparoscopic image of glistening nodules on the peri-
toneal surface.
Histopathology for the biopsies taken from the peritoneal
nodules reported the presence of chronic inflammation and
noncaseating granulomata (Figure 3). There were no atypical
lymphoid cells or immature granulocytes visualised; no evi-
dence of malignancy or vasculitis and no fungi or acid fast
bacilli were grown on extended culture with Grocott and
Ziehl-Neelson staining. The patient was admitted 6 times
with an interval of 7–10 days to have abdominal paracentesis,
every time aspirating 4-5 litres. QuantiFERON test was
performed to rule out abdominal tuberculosis and it turned
out to be negative.
Based on these results, the patient was commenced on an
empirical dose of 25mg prednisolone and subsequently her
symptoms fully resolved. Residual omental thickening was
not present in the repeatMRI scan and she no longer required
any further paracentesis.
Having excluded the more common causes of granulo-
mata including tuberculosis, fungal infection, autoimmune
Figure 3: Biopsy of peritoneal nodules showing noncaseating
histiocytic granulomas.
disease, and neoplasia, this left us with a likely diagno-
sis of abdominal sarcoidosis. Serum angiotensin-converting
enzyme level was normal (54).
2. Discussion
Sarcoidosis typically presents with lung involvement or the
classic tetrad of fever, bilateral hilar lymphadenopathy, ery-
thema nodosum, and arthralgia; however, 10% of patients
present with extrathoracic involvement, most often hepatic
[1]. Ascites can occur and is most often transudate, sec-
ondary to pulmonary hypertension or portal hypertension
due to granulomatous obstruction.However, there are a small
number of case reports (a search of the Medline database
returned a total of 28) reporting transudative or exudative
ascites associated with peritoneal or serosal sarcoid studding
[2]. This is associated with a significant elevation in serum
CA125, as seen in our patient. Isolated ascites in sarcoidosis
is usually benign and highly responsive to steroids, a feature
again seen in our patient.
ACE is produced by sarcoid granulomas, and serumACE
levels are used to correlate with disease load [2]. Elevated
serum ACE occurs in approximately 60% of patients with
sarcoidosis. However, having a normal ACE level as in our
patient does not exclude the diagnosis.
There has been several previous case reports of sar-
coidosis associated with a diagnosis of AML. Of these, only
three reported AML preceding the diagnosis of sarcoidosis,
with intervals ranging from 11 months to 17 years [3–5].
The case presented here adds to list, with an interval of 8
months between the diagnosis of AML and sarcoidosis. To
our knowledge this is the only case report of peritoneal sar-
coidosis following a diagnosis of AML. There have been no
previous cases revealed on extensive literature searches.
The exact relationship between AML and sarcoidosis is
unclear. It has been hypothesised that the granulomatous
inflammation observed in sarcoidosis may occur in reaction
to tumour-associated antigens that are widespread in AML.
In addition, the transmission of sarcoidosis or sarcoidosis-
inducing pathogens, for example, via bone marrow trans-
plantation, has been considered [6]. Our patient did not
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receive a bone marrow transplant, but she was treated with
several chemotherapeutic agents as part of the clinical trial.
Granulomatous disease has been associated with exposure to
chemotherapy agents, for example, capecitabine, interferon
beta, and particularly heavymetals ormethotrexate [7, 8]. It is
not clear whether this was a factor in the case presented here.
There have been no similar cases in the AML16 study cohort
to our knowledge, but this has been raised as a potential
adverse event with the trial centre. The relationship between
AML and sarcoidosis is an area that requires further study.
3. Conclusion
Thedistinctiveness of this case is the uncommonpresentation
of sarcoidosis, in association with a preexisting diagnosis
of AML. As mentioned in the discussion, our patient is a
participant of a clinical trial and a possible conjecture is
whether one of the chemotherapeutic drugs used could have
influenced the development of granulomas in our patient.
However no similar symptoms have been reported in other
trial patients to our knowledge.
We have highlighted this case as a possible late adverse
event to the trial centre and to the competent authority.
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